Cas:286390-50-9 [1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole manufacturer & supplier

We serve Chemical Name:[1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole CAS:286390-50-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

[1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole

Chemical Name:[1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole
CAS.NO:286390-50-9
Synonyms:Thiazolo[4,5-e]-2,1,3-benzoxadiazole(9CI)
Molecular Formula:C7H3N3OS
Molecular Weight:177.18300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:80.05000
Exact Mass:177.00000
LogP:1.83250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Thiazolo[4,5-e]-2,1,3-benzoxadiazole(9CI) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Thiazolo[4,5-e]-2,1,3-benzoxadiazole(9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Thiazolo[4,5-e]-2,1,3-benzoxadiazole(9CI) Use and application,Thiazolo[4,5-e]-2,1,3-benzoxadiazole(9CI) technical grade,usp/ep/jp grade.


Related News: Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei. [1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole manufacturer Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment. [1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole supplier Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei. [1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole vendor Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei. [1,3]thiazolo[5,4-g][2,1,3]benzoxadiazole factory Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.